Colonization with antibiotic-resistant Gram-negative organisms in a pediatric intensive care unit

Critical Care Medicine

Volumn 25, Issue 3, 1997, Pages 538-544

  Toltzis, Philip ^a,b   Yamashita, Toyoko ^a,b   Vilt, Lynn ^a,b   Blumer, Jeffrey L ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

aminoglycoside; antibiotic resistance; ceftazidime; drug utilization; nosocomial infection

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; CHILD; GRAM NEGATIVE BACTERIUM; HUMAN; INFANT; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; PEDIATRICS; PRIORITY JOURNAL;

CARRIER STATE; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DIGESTIVE SYSTEM; DRUG RESISTANCE, MICROBIAL; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS, PEDIATRIC; LOGISTIC MODELS; MICROBIAL SENSITIVITY TESTS; NASOPHARYNX; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 0030984574     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199703000-00026     Document Type: Article

References (45)

1. Burwen DR, Banerjee SN, Gaynes RP, et al: Ceftazidime resistance among selected nosocomial Gram-negative bacilli in the United States. J Infect Dis 1994; 170:1622-1625
2. Sirot DL, Goldstein FW, Soussy CJ, et al: Resistance to cefotaxime and seven other β-lactams in members of the family Enterobacteriaceae: A 3-year survey in France. Antimicrob Agents Chemother 1992; 36:1677-1681
3. Holmberg SD, Solomon SL, Blake PA: Health and economic impacts of antimicrobial resistance. Rev Infect Dis 1987; 9:1065-1078
4. Miller JP, Farr BM, Gwantley JM Jr: Economic benefits of an effective infection control program: Case study and proposal. Rev Infect Dis 1989; 11: 284-288
5. Chow JW, Fine MJ, Shlaes DM, et al: Enterobacter bacteremia: Clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991; 115:585-590
6. Naumovski L, Quinn JP, Miyashiro D, et al: Outbreak of ceftazidime resistance due to a novel extended spectrum β-lactamase in isolates from cancer patients. Antimicrob Agents Chemother 1992; 36:1991-1996
7. Welliver RC, McLaughlin S: Unique epidemiology of nosocomial infection in a children's hospital. Am J Dis Child 1984; 138:131-133
8. Milliken J, Tait GA, Ford-Jones EL, et al: Nosocomial infections in a pediatric intensive care unit. Crit Care Med 1988; 16:233-237
9. Ford-Jones EL, Mindorff CM, Langley JM, et al: Epidemiologic study of 4684 hospital-acquired infections in pediatric patients. Pediatr Infect Dis J 1989; 8: 668-675
10. McGowan JE: Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 1983; 6: 1033-1048
11. Sanders CC, Sanders WE Jr: Microbial resistance to newer generation β-lactam antibiotics: Clinical and laboratory implications. J Infect Dis 1985; 151: 399-406
12. McGowan JE: Is antimicrobial resistance in hospital microorganisms related to antibiotic use? Bull NY Acad Med 1987; 63:253-268
13. Selden R, Lee S, Wang WLL, et al: Nosocomial Klebsiella infections: Intestinal colonization as a reservoir. Ann Intern Med 1971; 74:657-664
14. Hammond JMJ, Potgieter PD, Forder AA, et al: Influence of amikacin as the primary aminoglycoside on bacterial isolates in the intensive care unit. Crit Care Med 1990; 18:607-610
15. Tullus K, Berglund B, Burman LG: Emergence of cross-resistance to β-lactam antibiotics in fecal Escherichia coli and Klebsiella strains from neonates treated with ampicillin or cefuroxime. Antimicrob Agents Chemother 1990; 34:361-362
16. Reisch O, Ashkenazi S, Naor N, et al: An outbreak of multiresistant Klebsiella in a neonatal intensive care unit. J Hosp Infect 1993; 25:287-291
17. Johnson MP, Ramphal R: β-lactam-resistant Enterobacter bacteremia in febrile neutropenic patients receiving monotherapy. J Infect Dis 1990; 162: 981-983
18. Bryan CS, John JF, Pai MS, et al: Gentamicin vs. cefotaxime for therapy of neonatal sepsis. Am J Dis Child 1985; 139:1086-1089
19. Meyer KS, Urban C, Eagan JA, et al: Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993; 119:353-358
20. Rice LB, Willey SH, Papanicolaou GA, et al: Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother 1990; 43:2193-2199
21. Daschner F, Langmaack H, Wiedemann B: Antibiotic resistance in intensive care unit areas. Infection Control 1983; 4: 382-387
22. Quinn JP, Di Vincenzo CA, Foster J: Emergence of resistance to ceftazidime during therapy for Enterobacter cloacae infections. J Infect Dis 1987; 155: 942-947
23. Jacobson KL, Cohen SH, Inciardi JF, et al: The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I b-lactamase-producing organisms. Clin Infect Dis 1995; 21:1107-1113
24. Weinstein RA: Epidemiology and control of nosocomial infections in adult intensive care units. Am J Med 1991; 91(Suppl3B):179S-184S
25. Brown RB, Hosmer D, Chen HC, et al: A comparison of infections in different ICUs within the same hospital. Crit Care Med 1985; 13:472-476
26. Jarvis WR, Edwards JR, Culver DH, et al: Nosocomial infection rates in adult and pediatric intensive care units in the United States. Am J Med 1991; 91(Suppl 3B):185S-191S
27. Bjerke HS, Leyerle B, Shabot MM: Impact of intensive care unit nosocomial infections on outcome from surgical care. Am Surg 1991; 57:798-802
28. Johanson WG, Pierce AK, Sanford JP: Changing pharyngeal bacterial flora of hospitalized patients: Emergence of Gram-negative bacilli. N Engl J Med 1969; 281:1137-1140
29. Johanson WG Jr, Pierce AK, Sanford JP, et al: Nosocomial respiratory infections with Gram-negative bacilli: The significance of colonization of the respiratory tract. Ann Intern Med 1972; 77: 701-706
30. Schwartz SN, Dowling JN, Benkovic C, et al: Sources of Gram-negative bacilli colonizing the tracheae of intubated patients. J Infect Dis 1978; 138:227-231
31. Ismaeel NA: Colonization of intensive care unit patients by Pseudomonas aeruginosa. J Hosp Infect 1993; 25: 279-286
32. Pittet D: Nosocomial blood-stream infections. In: Prevention and Control of Nosocomial Infections. Wenzel RP (Ed). Baltimore, William & Wilkins, 1993, pp 512-555
33. Craven DE, Steger KA, Duncan RA: Prevention and control of nosocomial pneumonia. In: Prevention and Control of Nosocomial Infections. Wenzel RP (Ed). Baltimore, William & Wilkins, 1993, pp 580-599
34. Pollack MM, Ruttimann UE, Getson PR: Pediatric risk of mortality (PRISM) score. Crit Care Med 1988; 16:1100-1106
35. Garner JS, Jarvis WR, Emori TG, et al: CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128-140
36. National Committee for Clinical Laboratory Standards: Dilution procedures for susceptibility testing of aerobic bacteria. Approved Standard NCCLS Publication M7-A3, Villanova, PA, NCCLS, 1993
37. Glantz SA, Slinker BK: Primer of Applied Regression and Analysis of Variance. New York, McGraw Hill, 1990
38. Bingen E, Denamur E, Lambert-Zechovsky N, et al: Rapid genotyping shows the absence of cross-contamination in Enterobacter cloacae nosocomial infections. J Hosp Infect 1992; 21:95-101
39. Chetchotisakd P, Phelps CL, Harstein AI: Assessment of bacterial cross-contamination as a cause of infections in patients in intensive care units. Clin Infect Dis 1994; 18:929-937
40. Flynn DM, Weinstein RA, Nathan C, et al: Patients' endogenous flora as the source of "nosocomial" Enterobacter in cardiac surgery. J Infect Dis 1987; 156: 363-368
41. Rose HD, Babcock JB: Colonization of intensive care unit patients with Gram-negative bacilli. Am J Epidemiol 1975; 101:495-501
42. Leonard EM, van Saene HKF, Shears P, et al: Pathogenesis of colonization and infection in a neonatal surgical unit. Crit Care Med 1990; 18:264-269
43. Berkowitz FE, Metchock B: Third generation cephalosporin-resistant Gram-negative bacilli in the feces of hospitalized children. Pediatr Infect Dis J 1995; 14:97-100
44. Bush K, Jacoby GA, Medeiros AA: A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995; 39:1211-1233
45. Shay DK, Maloney SA, Montecalvo M, et al: Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infection. J Infect Dis 1995; 172:993-1000